Cargando…
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314876/ https://www.ncbi.nlm.nih.gov/pubmed/35864270 http://dx.doi.org/10.1007/s00432-022-04096-w |
_version_ | 1785067401122938880 |
---|---|
author | Huemer, Florian Hecht, Stefan Scharinger, Bernhard Schlintl, Verena Rinnerthaler, Gabriel Schlick, Konstantin Heregger, Ronald Melchardt, Thomas Wimmer, Angela Mühlbacher, Iris Koch, Oliver Owen Neureiter, Daniel Klieser, Eckhard Seyedinia, Sara Beheshti, Mohsen Greil, Richard Weiss, Lukas |
author_facet | Huemer, Florian Hecht, Stefan Scharinger, Bernhard Schlintl, Verena Rinnerthaler, Gabriel Schlick, Konstantin Heregger, Ronald Melchardt, Thomas Wimmer, Angela Mühlbacher, Iris Koch, Oliver Owen Neureiter, Daniel Klieser, Eckhard Seyedinia, Sara Beheshti, Mohsen Greil, Richard Weiss, Lukas |
author_sort | Huemer, Florian |
collection | PubMed |
description | PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidisciplinary approach and the impact on clinical outcomes. METHODS: This retrospective, single-center study was based on medical records and (FDG-PET)-CT images among gastric/GEJ cancer patients undergoing perioperative FLOT chemotherapy. RESULTS: Between 2016 and 2021, 46 gastric/GEJ cancer patients started perioperative FLOT at our tertiary cancer center (Salzburg, Austria). At a median follow-up of 32 months median PFS was 47.4 months and median OS was not reached. The skeletal muscle index (SMI, cm(2)/m(2)) turned out to be the only body composition parameter with a statistically significant decrease during pre-operative FLOT (51.3 versus 48.8 cm(2)/m(2), p = 0.02). Neither pre-FLOT body mass index (BMI), nor SMI had an impact on the duration of pre-operative FLOT, the time interval from pre-operative FLOT initiation to surgery, the necessity of pre-operative or post-operative FLOT de-escalation or the likelihood of the start of postoperative chemotherapy. Pre-FLOT BMI (overweight versus normal, HR: 0.11, 95% CI: 0.02–0.65, p = 0.02) and pre-FLOT SMI (sarcopenia versus no sarcopenia, HR: 5.08, 95% CI: 1.27–20.31, p = 0.02) were statistically significantly associated with PFS in the multivariable analysis. CONCLUSION: The statistically significant SMI loss during pre-operative FLOT and the meaningful impact of baseline SMI and BMI on PFS argue for the implementation of a nutritional screening and support program prior to the initiation of pre-operative FLOT in clinical routine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04096-w. |
format | Online Article Text |
id | pubmed-10314876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103148762023-07-03 Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol Huemer, Florian Hecht, Stefan Scharinger, Bernhard Schlintl, Verena Rinnerthaler, Gabriel Schlick, Konstantin Heregger, Ronald Melchardt, Thomas Wimmer, Angela Mühlbacher, Iris Koch, Oliver Owen Neureiter, Daniel Klieser, Eckhard Seyedinia, Sara Beheshti, Mohsen Greil, Richard Weiss, Lukas J Cancer Res Clin Oncol Research PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidisciplinary approach and the impact on clinical outcomes. METHODS: This retrospective, single-center study was based on medical records and (FDG-PET)-CT images among gastric/GEJ cancer patients undergoing perioperative FLOT chemotherapy. RESULTS: Between 2016 and 2021, 46 gastric/GEJ cancer patients started perioperative FLOT at our tertiary cancer center (Salzburg, Austria). At a median follow-up of 32 months median PFS was 47.4 months and median OS was not reached. The skeletal muscle index (SMI, cm(2)/m(2)) turned out to be the only body composition parameter with a statistically significant decrease during pre-operative FLOT (51.3 versus 48.8 cm(2)/m(2), p = 0.02). Neither pre-FLOT body mass index (BMI), nor SMI had an impact on the duration of pre-operative FLOT, the time interval from pre-operative FLOT initiation to surgery, the necessity of pre-operative or post-operative FLOT de-escalation or the likelihood of the start of postoperative chemotherapy. Pre-FLOT BMI (overweight versus normal, HR: 0.11, 95% CI: 0.02–0.65, p = 0.02) and pre-FLOT SMI (sarcopenia versus no sarcopenia, HR: 5.08, 95% CI: 1.27–20.31, p = 0.02) were statistically significantly associated with PFS in the multivariable analysis. CONCLUSION: The statistically significant SMI loss during pre-operative FLOT and the meaningful impact of baseline SMI and BMI on PFS argue for the implementation of a nutritional screening and support program prior to the initiation of pre-operative FLOT in clinical routine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04096-w. Springer Berlin Heidelberg 2022-07-21 2023 /pmc/articles/PMC10314876/ /pubmed/35864270 http://dx.doi.org/10.1007/s00432-022-04096-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Huemer, Florian Hecht, Stefan Scharinger, Bernhard Schlintl, Verena Rinnerthaler, Gabriel Schlick, Konstantin Heregger, Ronald Melchardt, Thomas Wimmer, Angela Mühlbacher, Iris Koch, Oliver Owen Neureiter, Daniel Klieser, Eckhard Seyedinia, Sara Beheshti, Mohsen Greil, Richard Weiss, Lukas Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title | Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title_full | Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title_fullStr | Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title_full_unstemmed | Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title_short | Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol |
title_sort | body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the flot protocol |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314876/ https://www.ncbi.nlm.nih.gov/pubmed/35864270 http://dx.doi.org/10.1007/s00432-022-04096-w |
work_keys_str_mv | AT huemerflorian bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT hechtstefan bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT scharingerbernhard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT schlintlverena bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT rinnerthalergabriel bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT schlickkonstantin bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT hereggerronald bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT melchardtthomas bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT wimmerangela bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT muhlbacheriris bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT kocholiverowen bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT neureiterdaniel bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT kliesereckhard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT seyediniasara bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT beheshtimohsen bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT greilrichard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol AT weisslukas bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol |